Kim LufkinGHTC
Kim Lufkin is a communications officer at GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Building on a 2009 trial that demonstrated a preventive HIV vaccine is possible, researchers in Thailand are moving forward with another phase of an HIV vaccine study.
The American Society for Biochemistry and Molecular Biology has released a survey that found 96 percent of scientists say that research budgets are not growing fast enough to keep up with scientific opportunities.
Pharmaceutical company Sanofi Pasteur announced that the World Health Organization has prequalified Menomune®, its vaccine to prevent invasive meningococcal disease.
A new opinion piece argues that there has been “measurable progress” made in “developing a safe, effective microbicide,” which is a “tribute to the tenacity of advocates and scientists alike.”
In the lead up to the United Nations General Assembly later this month, a new online debate asks some of the world's leading experts about changes needed to achieve the health-related Millennium Development Goals by the deadline.